Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Nanofiber-based delivery of therapeutic peptides to the brain.

Mazza M, Notman R, Anwar J, Rodger A, Hicks M, Parkinson G, McCarthy D, Daviter T, Moger J, Garrett N, Mead T, Briggs M, Schätzlein AG, Uchegbu IF.

ACS Nano. 2013 Feb 26;7(2):1016-26. doi: 10.1021/nn305193d. Epub 2013 Jan 10.

PMID:
23289352
2.

Peptide nanofiber complexes with siRNA for deep brain gene silencing by stereotactic neurosurgery.

Mazza M, Hadjidemetriou M, de Lázaro I, Bussy C, Kostarelos K.

ACS Nano. 2015 Feb 24;9(2):1137-49. doi: 10.1021/nn5044838. Epub 2015 Jan 21.

PMID:
25574683
3.

A strategy for delivering peptides into the central nervous system by sequential metabolism.

Bodor N, Prokai L, Wu WM, Farag H, Jonalagadda S, Kawamura M, Simpkins J.

Science. 1992 Sep 18;257(5077):1698-700.

PMID:
1529356
4.

Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.

Rousselle C, Clair P, Smirnova M, Kolesnikov Y, Pasternak GW, Gac-Breton S, Rees AR, Scherrmann JM, Temsamani J.

J Pharmacol Exp Ther. 2003 Jul;306(1):371-6. Epub 2003 Apr 7.

5.

Lipopeptide delivery of siRNA to the central nervous system.

Zabel MD.

Methods Mol Biol. 2013;948:251-62. doi: 10.1007/978-1-62703-140-0_17.

PMID:
23070775
6.

Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats.

Valiante S, Falanga A, Cigliano L, Iachetta G, Busiello RA, La Marca V, Galdiero M, Lombardi A, Galdiero S.

Int J Nanomedicine. 2015 Mar 10;10:1885-98. doi: 10.2147/IJN.S77734. eCollection 2015.

7.

Delivery of analgesic peptides to the brain by nano-sized bolaamphiphilic vesicles made of monolayer membranes.

Popov M, Abu Hammad I, Bachar T, Grinberg S, Linder C, Stepensky D, Heldman E.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):381-9. doi: 10.1016/j.ejpb.2013.06.005. Epub 2013 Jun 18.

PMID:
23791683
8.

Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier.

Schroeder U, Sommerfeld P, Sabel BA.

Peptides. 1998;19(4):777-80.

PMID:
9622035
9.

Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain.

Sarkar G, Curran GL, Sarkaria JN, Lowe VJ, Jenkins RB.

PLoS One. 2014 May 21;9(5):e97655. doi: 10.1371/journal.pone.0097655. eCollection 2014.

10.

Supramolecular nanofibers of self-assembling peptides and proteins for protein delivery.

Wang H, Wang Y, Zhang X, Hu Y, Yi X, Ma L, Zhou H, Long J, Liu Q, Yang Z.

Chem Commun (Camb). 2015 Sep 28;51(75):14239-42. doi: 10.1039/c5cc03835a. Epub 2015 Aug 12.

PMID:
26264079
11.

A novel peptide delivers plasmids across blood-brain barrier into neuronal cells as a single-component transfer vector.

Fu A, Zhang M, Gao F, Xu X, Chen Z.

PLoS One. 2013;8(3):e59642. doi: 10.1371/journal.pone.0059642. Epub 2013 Mar 29.

12.

Shape-specific nanofibers via self-assembly of three-branched peptide.

Koga T, Matsui H, Matsumoto T, Higashi N.

J Colloid Interface Sci. 2011 Jun 1;358(1):81-5. doi: 10.1016/j.jcis.2011.02.055. Epub 2011 Mar 1.

PMID:
21429499
13.

Peptide pills for brain diseases? Reality and future perspectives.

Serrano Lopez DR, Lalatsa A.

Ther Deliv. 2013 Apr;4(4):479-501. doi: 10.4155/tde.13.5. Review.

PMID:
23557289
14.

Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.

Lalatsa A, Schätzlein AG, Garrett NL, Moger J, Briggs M, Godfrey L, Iannitelli A, Freeman J, Uchegbu IF.

J Control Release. 2015 Jan 10;197:87-96. doi: 10.1016/j.jconrel.2014.10.028. Epub 2014 Nov 5.

15.

Polymersomes conjugated with des-octanoyl ghrelin for the delivery of therapeutic and imaging agents into brain tissues.

Chen YC, Chiang CF, Chen LF, Liao SC, Hsieh WY, Lin WL.

Biomaterials. 2014 Feb;35(6):2051-65. doi: 10.1016/j.biomaterials.2013.11.051. Epub 2013 Dec 7.

PMID:
24315575
16.

Nanofibrous scaffold from self-assembly of beta-sheet peptides containing phenylalanine for controlled release.

Zhao Y, Tanaka M, Kinoshita T, Higuchi M, Tan T.

J Control Release. 2010 Mar 19;142(3):354-60. doi: 10.1016/j.jconrel.2009.11.016. Epub 2009 Nov 22.

PMID:
19932721
17.

Challenges and new strategies for therapeutic peptide delivery to the CNS.

McGowan JW, Bidwell GL 3rd, Vig PJ.

Ther Deliv. 2015 Jul;6(7):841-53. doi: 10.4155/tde.15.30. Review.

PMID:
26228775
18.

Nanoparticle technology for delivery of drugs across the blood-brain barrier.

Schroeder U, Sommerfeld P, Ulrich S, Sabel BA.

J Pharm Sci. 1998 Nov;87(11):1305-7.

PMID:
9811481
19.

Local delivery of proteins and the use of self-assembling peptides.

Segers VF, Lee RT.

Drug Discov Today. 2007 Jul;12(13-14):561-8. Epub 2007 Jun 26. Review.

PMID:
17631251
20.

The proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with lactoferrin.

Yu Y, Jiang X, Gong S, Feng L, Zhong Y, Pang Z.

Nanoscale. 2014 Mar 21;6(6):3250-8. doi: 10.1039/c3nr05196j. Epub 2014 Feb 7.

PMID:
24503971

Supplemental Content

Support Center